Regeneron Pharmaceuticals, Inc.

Unlock to Claim this listing
Add / Modify Company

Regeneron Pharmaceuticals, Inc. is a biotechnology company dedicated to molecules signaling, and targeted antibody drugs. Thanks to its patented treatments and technologies, Regeneron provides remedies for eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic diseases, infectious diseases, and rare diseases.

Click to rate this company
[Total: 0 Average: 0]

3.7

Overall Excellence Rating

Industry

Healthcare

Category

Biotech & Pharmaceuticals

ESG/Ethical Impact

Our commitment to protect the health of the planet is closely tied to our mission to improve the health of patients. As we continue to grow and expand our operations, we keep the environment front of mind. Our environmental targets reflect our ambitions to mitigate our GHG emissions, increase our use of renewable energy, minimize waste and enhance water stewardship. Our efforts are guided by our global EHS policy, which Regeneron’s senior management team is accountable for enforcing across all teams. In 2022, we conducted an enterprise-wide assessment to better understand the key drivers of our GHG emissions and forecast how they might evolve as we continue to grow. We also held a series of cross-functional, internal workshops to identify opportunities to reduce our emissions. We used these insights to develop an action plan to meet our existing targets and prepare for the future.Regeneron continues our work to deliver needed new medicines to patients. Our pipeline is composed of primarily homegrown therapeutics and powered by end-to-end research and development capabilities. Our team of researchers continues to transform and accelerate the traditional drug discovery process, enabled by our proprietary VelociSuite technologies and informed by discoveries being made in our RGC and across our R&D groups. We are expanding our technological toolkit with new genetic medicine capabilities to bolster our portfolio and diversify the diseases we can treat in the future. Our Global Development team brings investigational candidates through the full clinical development process, from trial design to study execution and lifecycle management. To facilitate continued innovation, protect patients and promote collaboration, we actively protect intellectual property (IP) rights in our innovations and discoveries. It can cost billions of dollars and many years to discover, test, validate and obtain approval for just a single biologic medicine. By protecting our IP, we prevent others from inappropriately benefiting from our hard work and investment. IP also helps ensure patients receive authentic, safe and effective treatments by precluding others from making substandard copies or importing counterfeits of our medicines. It is similarly foundational in the promotion of global collaborations by allowing us to openly share our ideas and advancements with the hopes of spurring additional innovations. Our patent portfolio and IP strategy are subject to close review by senior management on a regular basis. Our robust governance, policies and procedures and strong moral compass inform the work we do every day at Regeneron. The rigor of our scientific purpose is reflected in how we operate our business, from our clinical trials to product quality and supply chain management — all with a focus on delivering the best outcomes for patients. Strong corporate governance is the cornerstone to our success and underpins our long-term business strategy. We believe that good corporate governance promotes the long-term interests of stakeholders and helps build trust in Regeneron. We continually Women work to maintain effective governance, appropriate oversight and 3 clear accountability across our business. Regeneron’s Board of Directors consists of 13 directors. Since 1995, the Board has separated the roles of the CEO and the Directors Chair of the Board. In addition, 77 percent of our 13 directors are independent, and only independent Board members serve on key standing committees. Regeneron is a biopharmaceutical company with a focus on research and development of innovative therapies. The company’s strong pipeline and collaborations contribute to its financial stability. Biopharmaceutical Innovator: Regeneron focuses on developing innovative therapies, particularly in areas like immunology, oncology, and rare diseases. Research and Collaboration: The company’s research efforts and collaborations contribute to its financial sustainability and impact on patient health.Acting ethically and with integrity is foundational to Regeneron’s culture and is essential to putting patients first and making our business thrive. Our Board, CEO and members of our senior leadership team are committed to governing our company through ethical and compliant business strategies. The effectiveness of our corporate compliance program begins with their leadership. Our Chief Compliance Officer directs our program, reinforces our culture of ethics and integrity and provides regular updates to the Corporate Governance and Compliance Committee of our Board. Our Corporate Compliance team is integrated into our business units to help ensure that compliance resources are available throughout the organization. In 2022, we separated our Compliance Operations and Advisory Services team into two distinct teams to support the growth of Regeneron globally and in the United States. This new structure allows us to delve deeper into each respective area to help ensure our program continues to meet societal expectations of an effective compliance program and the current and future needs of the organization.

Eligible Awards

Coming Soon

Claim Your Award Badges

Do you work with Us

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer.

Awards Received

2023

Revenues

$12,100,000,000.00

Website Traffic

Employee Rating

4

Customer Rating

3.7

Company Size

10000+

ESG Risk Rating

4

We’re Happy to Help.

Do you have questions about your ranking, our projects, or why you’re not on the list?
Scroll to Top

Excellence In My Industry

This badge tells your customers, employees, partners, and other stakeholders that your company has met the criteria of our excellence certification in best practices across all pillars of business in your specific industry – from financial responsibility and results, sustainability, social responsibility, employee experience, customer satisfaction, ethics, and more.

Best Practice Certified

This badge tells your customers, employees, partners, and other stakeholders that your company has met the criteria of our excellence certification in best practices across all pillars of business – from financial responsibility and results, sustainability, social responsibility, employee experience, customer satisfaction, ethics, and more.

Best of Best Practices

This badge tells your customers, employees, partners, and other stakeholders that your company is one of the top 20 companies in your industry that has met the criteria for our excellence certification in best practices across all pillars of business – from financial responsibility and results, sustainability, social responsibility, employee experience, customer satisfaction, ethics, and more.

Newsweek Excellence 1000

This badge tells your customers, employees, partners, and other stakeholders that your company is one of the Top 1000 companies that demonstrate excellence across all pillars of business – from financial responsibility and results, sustainability, social responsibility, employee experience, customer satisfaction, ethics, and more.